THMO · Thermogenesis Holdings, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $1.53M | - | $1.80M | $1.80M | $1.47M | - | $1.68M | $2.09M | $1.72M | - |
| Gross Profit | $1.20M | - | $395.0K | $469.0K | $1.10M | - | $437.0K | $939.0K | $940.0K | - |
| R&D | $211.0K | - | $266.0K | $383.0K | $306.0K | - | $470.0K | $392.0K | $456.0K | - |
| SG&A | $1.55M | - | $1.69M | $1.82M | $1.84M | - | $1.98M | $1.99M | $1.69M | - |
| Total Operating Expenses | $1.76M | - | $1.95M | $2.20M | $2.15M | - | $2.45M | $2.38M | $2.15M | - |
| D&A | $334.0K | - | - | - | $267.0K | - | - | - | $150.0K | - |
| Operating Income | ($557.0K) | - | ($1.56M) | ($1.73M) | ($1.04M) | - | ($2.02M) | ($1.44M) | ($1.21M) | - |
| Interest Expense | $1.45M | - | $2.12M | $668.0K | $3.90M | - | $1.39M | $1.36M | $823.0K | - |
| Income Tax | - | - | - | - | - | - | - | - | - | - |
| Net Income | ($1.86M) | - | ($3.62M) | ($2.26M) | ($5.09M) | - | ($3.24M) | ($2.69M) | ($1.91M) | - |
| EPS - Basic | ($0.46) | - | ($1.44) | ($0.91) | ($4.07) | - | ($6.75) | ($9.00) | ($7.20) | - |
| EPS - Diluted | - | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Line item | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.18M | $2.00M | $4.02M | $4.45M | $5.85M | $4.18M | $3.90M | $4.00M | $3.65M | $7.28M |
| Accounts Receivable | $1.15M | $949.0K | $368.0K | $774.0K | $955.0K | $1.86M | $2.06M | $2.31M | $2.17M | $733.0K |
| Inventory | $1.25M | $1.41M | $1.82M | $2.66M | $3.43M | $3.33M | $4.91M | $5.49M | $5.89M | $5.37M |
| Accounts Payable | $988.0K | $948.0K | $591.0K | $508.0K | $934.0K | $820.0K | $1.01M | $1.24M | $1.87M | $1.28M |
| Current Assets | $4.35M | $5.18M | $6.92M | $8.45M | $10.97M | $10.88M | $11.48M | $12.48M | $13.19M | $14.96M |
| Total Assets | $10.09M | $11.23M | $15.92M | $17.61M | $19.75M | $19.39M | $20.09M | $21.33M | $18.28M | $20.65M |
| Current Liabilities | $8.30M | $11.76M | $8.89M | $10.99M | $10.47M | $11.51M | $10.97M | $10.69M | $15.48M | $6.35M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $11.17M | $14.82M | $12.66M | $14.98M | $14.74M | $16.06M | $15.83M | $15.82M | $17.00M | $17.25M |
| Stockholders' Equity | $975.0K | ($1.67M) | $4.59M | $3.83M | $6.08M | $4.30M | $5.10M | $6.18M | $1.84M | $3.83M |
| Retained Earnings | ($286.02M) | ($284.17M) | ($277.15M) | ($273.54M) | ($271.28M) | ($266.19M) | ($262.76M) | ($259.52M) | ($256.83M) | ($264.66M) |
Cash Flow
| Line item | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($505.0K) | - | - | - | ($615.0K) | - | - | - | ($4.16M) | - |
| Investing Cash Flow | ($20.0K) | - | - | - | ($771.0K) | - | - | - | ($65.0K) | - |
| Financing Cash Flow | ($299.0K) | - | - | - | $3.06M | - | - | - | $594.0K | - |
| CapEx | $20.0K | - | - | - | $771.0K | - | - | - | $65.0K | - |
| Free Cash Flow | ($525.0K) | - | - | - | ($1.39M) | - | - | - | ($4.22M) | - |
Ratios
| Metric | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | 0.28 | - | - | - | 0.27 | - | - | - | 2.21 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -18.4% | - | -22.7% | -12.8% | -25.8% | - | -16.1% | -12.6% | -10.4% | - |
| Return on equity | -190.4% | - | -78.7% | -58.9% | -83.6% | - | -63.5% | -43.5% | -103.9% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 0.52 | 0.44 | 0.78 | 0.77 | 1.05 | 0.95 | 1.05 | 1.17 | 0.85 | 2.36 |
| Quick ratio | 0.37 | 0.32 | 0.57 | 0.53 | 0.72 | 0.66 | 0.60 | 0.65 | 0.47 | 1.51 |
| Cash ratio | 0.14 | 0.17 | 0.45 | 0.41 | 0.56 | 0.36 | 0.36 | 0.37 | 0.24 | 1.15 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | -0.4x | - | -0.7x | -2.6x | -0.3x | - | -1.4x | -1.1x | -1.5x | - |
| Equity multiplier | 10.35 | -6.74 | 3.46 | 4.59 | 3.25 | 4.51 | 3.94 | 3.45 | 9.94 | 5.39 |
| Liabilities / Assets | 1.11 | 1.32 | 0.80 | 0.85 | 0.75 | 0.83 | 0.79 | 0.74 | 0.93 | 0.84 |
| Efficiency | ||||||||||
| Asset turnover | - | - | - | - | - | - | - | - | - | - |
| Inventory turnover | 1.23 | - | 0.99 | 0.68 | 0.43 | - | 0.34 | 0.38 | 0.29 | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | 296d | - | 369d | 537d | 852d | - | 1068d | 959d | 1248d | - |
| Days payable outstanding | 235d | - | 120d | 103d | 232d | - | 219d | 217d | 395d | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | 8.8% | - | -9.6% | -50.1% | 17.6% | - | -60.8% | -4.8% | 32.8% | - |
| Operating income growth (YoY) | 46.7% | - | 22.7% | -20.0% | 13.6% | - | -82.4% | 54.0% | 27.3% | - |
| Net income growth (YoY) | 63.5% | - | -11.6% | 15.9% | -166.3% | - | -82.6% | 40.8% | 20.8% | - |
| EPS growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | 62.1% | - | - | - | 67.2% | - | - | - | -6.2% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -84.0% | - | -9.9% | -38.0% | 230.7% | 12.2% | -19.9% | -23.2% | -82.4% | -34.0% |
Peer comparison
Same SIC group: Laboratory Apparatus & Furniture
| Company | Revenue (last FY) | Net margin | ROE |
|---|---|---|---|
| KEQU | - | - | - |
Comparing ThermoGenesis Holdings against the 1 most active filer in the same SIC group.